Wiley-Blackwell Publishing, Inc
International Standard Serial Number (ISSN)
Electronic International Standard Serial Number (EISSN)
publication venue for
Liver Graft Preservation Using Perfluorocarbon Improves the Outcomes of Simulated Donation After Cardiac Death Liver Transplantation in Rats
Interferon-Free Therapy for Genotype 1 Hepatitis C in Liver Transplant Recipients: Real-World Experience From the Hepatitis C Therapeutic Registry and Research Network
Liver Transplant and the Bloody Glove: Treat Dieulafoy Before You Acquit
Successful Management of Pediatric Liver Transplant for Fulminant Hepatic Failure (Fhf) Without An Icp Monitor.
Sinusoidal C4d deposits in liver allografts indicate an antibody-mediated response: diagnostic considerations in the evaluation of liver allografts
Complement component 4d immunohistochemistry in the assessment of liver allograft biopsy samples: applications and pitfalls
Phoenix: a Randomized Controlled Trial of Peginterferon Alfa-2a Plus Ribavirin as a Prophylactic Treatment After Liver Transplantation for Hepatitis C Virus
Liver allograft antibody-mediated rejection with demonstration of sinusoidal C4d staining and circulating donor-specific antibodies
Long-term survival after 67 hours of anhepatic state due to primary liver allograft nonfunction
The Natural History of Hepatitis C Cirrhosis After Liver Transplantation
Explanted Liver Inflammatory Grade Predicts Fibrosis Progressive in Hepatitis C Recurrence
Intraoperative Red Cell and Platelet Transfusion Have No Effect On Survival Or Histologic Disease Recurrence in Hepatitis C Patients After Liver Transplantation
The Cvp Zero Reference and Hepatic Surgery.
Using An Immune Functional Assay To Differentiate Acute Cellular Rejection From Recurrent Hepatitis C in Liver Transplant Patients
The natural history of hepatitis C cirrhosis after liver transplantation.
Early histologic changes in fibrosing cholestatic hepatitis C.
Effect of prophylaxis on fungal infection and costs for high-risk liver transplant recipients.
Cyclosporine Suppresses Hepatitis C In Vitro and Increases the Chance of a Sustained Virological Response After Liver Transplantation
Impact of implementation of the MELD Scoring system on the prevalence and incidence of chronic liver disease following liver transplantation
Cyclosporine suppresses hepatitis C virus in vitro and increases the chance of a sustained virological response after liver transplantation.
Late presentation of a biliary tract complication after right hepatic donation resulting in secondary biliary cirrhosis.
A randomized, open-label study to evaluate the safety and pharmacokinetics of human hepatitis C immune globulin (Civacir) in liver transplant recipients
Early Hepatic Stellate Cell Activation Is Associate With Advanced Fibrosis after Liver Transplantation In Recipients With Hepatitis C
One-year protocol liver biopsy can stratify fibrosis progression in liver transplant recipients with recurrent hepatitis C infection.
Sustained viral response to interferon and ribavirin in liver transplant recipients with recurrent hepatitis C.
Tobacco use before and after liver transplantation: a single center survey and implications for clinical practice and research.
Lack of antiviral effect of a short course of mycophenolate mofetil in patients with chronic hepatitis C virus infection.
Metastatic leiomyosarcoma mimicking polycystic liver disease
Delayed neuropsychologic dysfunction after liver transplantation for acute liver failure: a matched, case-controlled study
Tacrolimus dosing requirements and concentrations in adult living donor liver transplant recipients
Combination Of Interferon Alfa-2b and Ribavirin in liver transplant recipients with histologic recurrent hepatitis C
Anti-interleukin-2 receptor therapy in combination with mycophenolate mofetil is associated with more severe hepatitis C recurrence after liver transplantation.